Bacteria Set Off Viral “Bombs” Inside Neighbors

A study finds some E. coli can deploy a chemical called colibactin to reawaken long-dormant viruses inside bacteria, causing destruction.

Written byNatalia Mesa, PhD
| 2 min read
Bacteriophage (green) attacking a bacterium (orange)
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Certain E. coli strains can engage in a form of bacterial warfare by producing colibactin, a chemical that can awaken long-dormant viruses inside neighboring cells’ DNA, sometimes resulting in their destruction, according to a new study published February 23 in Nature.

“It’s an interesting strategy, and it’s also a dangerous strategy,” Heather Hendrickson, an evolutionary microbiologist at the University of Canterbury in Christchurch, New Zealand, who was not involved in the work, tells Science News.

Throughout a bacterium’s life, bacteriophages—viruses that infect bacteria—insert their DNA into its genome. Typically, these embedded viruses, known as prophages, are harmless and lie dormant unless something triggers their escape. The study reports that E. coli can release colibactin, which damages neighbors’ DNA, triggering the bacteria’s DNA repair system, known as an SOS response. This releases prophage DNA from the bacteria’s genome, causing the virus to regain its virulence. Once these viruses are released from ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A black and white headshot

    As she was completing her graduate thesis on the neuroscience of vision, Natalia found that she loved to talk to other people about how science impacts them. This passion led Natalia to take up writing and science communication, and she has contributed to outlets including Scientific American and the Broad Institute. Natalia completed her PhD in neuroscience at the University of Washington and graduated from Cornell University with a bachelor’s degree in biological sciences. She was previously an intern at The Scientist, and currently freelances from her home in Seattle. 

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies